The estimated Net Worth of Michael J Valentino is at least $426 mil dollars as of 14 June 2021. Mr Valentino owns over 8,000 units of PLx Pharma stock worth over $19,788 and over the last 8 years he sold PLXP stock worth over $0. In addition, he makes $406,250 as Exec. Chairman at PLx Pharma.
Sign up
Mr Valentino PLXP stock SEC Form 4 insiders trading
Mr has made over 5 trades of the PLx Pharma stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 8,000 units of PLXP stock worth $99,840 on 14 June 2021.
The largest trade he's ever made was buying 264,900 units of PLx Pharma stock on 18 November 2020 worth over $1,003,971. On average, Mr trades about 37,140 units every 146 days since 2017. As of 14 June 2021 he still owns at least 494,690 units of PLx Pharma stock.
You can see the complete history of Mr Valentino stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Michael J. Valentino biography
Michael J. Valentino is the Exec. Chairman at PLx Pharma.
What is the salary of Mr Valentino?
As the Exec. Chairman of PLx Pharma, the total compensation of Mr Valentino at PLx Pharma is $406,250. There are 3 executives at PLx Pharma getting paid more, with Natasha Giordano having the highest compensation of $912,328.
How old is Mr Valentino?
Mr Valentino is 67, he's been the Exec. Chairman of PLx Pharma since . There are 6 older and 6 younger executives at PLx Pharma. The oldest executive at PLx Pharma Inc. is Patrick M. Lonergan, 86, who is the Member of Chief Exec. Officer Advisory Group.
What's Mr Valentino's mailing address?
Michael's mailing address filed with the SEC is 9 FISHERS LANE, SUITE E, SPARTA, NJ, 07871.
Insiders trading at PLx Pharma
Over the last 8 years, insiders at PLx Pharma have traded over $0 worth of PLx Pharma stock and bought 841,160 units worth $2,548,334 . The most active insiders traders include West Asset Management Llc Park, Michael J Valentino, eDavid Emerson Jorden. On average, PLx Pharma executives and independent directors trade stock every 124 days with the average trade being worth of $2,403. The most recent stock trade was executed by Natasha Giordano on 15 March 2022, trading 4,100 units of PLXP stock currently worth $14,965.
What does PLx Pharma do?
PLx Pharma Inc. is a late-stage specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard™ drug delivery platform to provide more effective and safer products. The PLxGuard drug delivery platform works by targeting the release of active pharmaceutical ingredients to various portions of the gastrointestinal (GI) tract. PLx believes this has the potential to improve the absorption of many drugs currently on the market or in development, and to reduce the risk of stomach erosions and ulcers associated with aspirin and ibuprofen, and potentially other drugs.
What does PLx Pharma's logo look like?
Complete history of Mr Valentino stock trades at PLx Pharma
PLx Pharma executives and stock owners
PLx Pharma executives and other stock owners filed with the SEC include:
-
Natasha Giordano,
CEO, Pres & Director -
Robert Shawah,
Chief Accounting Officer, Treasurer -
Rita M. O'Connor CPA, CPA,
CFO and Head of Manufacturing & Supply Chain -
Michael J. Valentino,
Exec. Chairman -
Michael Valentino,
Director -
John Hadden,
Director -
Natasha Giordano,
Director -
Robert Casale,
Director -
Kirk Calhoun,
Director -
Anthony Bartsh,
Director -
Gary Balkema,
Director -
Tom Long,
Vice President - Manufacturing & Technical Operations -
Steven Valentino,
Vice President - Trade Sales -
Rita O Connor,
Chief Financial Officer -
Harris Kaplan M.B.A., MBA,
Member of Chief Exec. Officer Advisory Group -
Janet M. Barth,
VP of Investor Relations & Corp. Communications -
Harris Kaplan MBA,
Member of Chief Exec. Officer Advisory Group -
Charles Edmund Sheedy C.F.A., CFA,
Member of Chief Exec. Officer Advisory Group -
Patrick M. Lonergan,
Member of Chief Exec. Officer Advisory Group -
Nicole Godino,
National Sales Director -
Joanne Cotignola,
VP of Marketing -
Ronald R. Zimmerman,
Founder & Sr. Advisor -
Efthymios Deliargyris,
Chief Medical Officer -
West Asset Management Llc Park,
10% owner -
David Emerson Jorden,
Acting Chief Financial Officer -
Gary L Mossman,
Chief Operating Officer -
David P Luci,
Director